Charles Schwab Investment Advisory, Inc. Pfizer Inc Transaction History

Charles Schwab Investment Advisory, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $290 Million - $319 Million	-7,737,382 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $5.76 Million - $6.56 Million	-149,645 Reduced 1.9%	7,737,382 $338 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $82,624 - $100,218	-2,397 Reduced 0.03%	7,887,027 $348 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $260 Million - $277 Million	7,889,424 New	7,889,424 $286 Million

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Advisory, Inc., based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Advisory, Inc. with notifications on news.